樂觀
$0.63
情境價格
$0.610
+0.006 (+1.04%)收盤時
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

DSS Inc. Cancels Proposed Public Offering

DSS, Inc. Launches Public Offering of Common Stock

DSS Withdraws S-1 Registration Statement Amid Market Conditions

DSS Announces 2025 Fiscal Year Audit Report with Going Concern Qualification

Insider at DSS Inc (DSS.US) Plans to Sell $23.06 Million in Common Stock via Form 144
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).
DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。